Because ipamorelin and GHRH analogs act through separate receptor pathways (GHS-R1a versus the GHRH receptor), preclinical research has investigated the two compound classes together, hypothesizing that dual-pathway stimulation may produce additive or synergistic effects on GH release compared with either pathway alone a design that leverages the cAMP/calcium signaling distinction described above
[DOI] [PubMed] [Google Scholar] 247.Vigil M., Berkson B.M., Garcia A.P
Note: A small human case series combining BPC-157 and TB-500 for joint injuries reported improved outcomes at higher combined doses (4 mg BPC + 6 mg TB-500 intra-articular) compared to lower doses [8]
See my post-workout shake recipe for how to boost its nutritional payload
Ashwini Kumar Banerjee 2 years ago 00:01:41 Crohn's, UC or Gut Sensitivity
In addition the insulin target tissues, 264 transcriptome profiling and different studies have identified several -cell specific lncRNAs that contribute to obesity-mediated -cell dysfunction and apoptosis